Mangoceuticals selects trybe labs as its nationwide blood collection and testing services provider

Trybe labs to provide mangorx customers with turnkey at-home blood collection services and solutions dallas, texas, nov. 29, 2023 (globe newswire) -- mangoceuticals, inc. (nasdaq: mgrx) (“mangorx” or the “company”), a company focused on developing, marketing, and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product branded ‘grow' and erectile dysfunction (ed) drug branded “mango,” today announced that it has selected trybe labs to provide its customers with a minimally invasive fda approved at-home blood collection device and testing services as the company seeks to further expand its product lines requiring blood tests and results reviewed by physicians. using innovative, fda approved at-home blood collection technology, trybe labs is a clia certified and joint commission accredited laboratory that provides a direct-to-consumer product which includes an easy-to-use collection kit, full range of testing, and physician-read results for male health and performance evaluation - including hormone, thyroid and vitamin levels.
MGRX Ratings Summary
MGRX Quant Ranking